These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 26840537)

  • 1. The Role of T Cell Costimulation via DNAM-1 in Kidney Transplantation.
    Kraus AK; Chen J; Edenhofer I; Ravens I; Gaspert A; Cippà PE; Mueller S; Wuthrich RP; Segerer S; Bernhardt G; Fehr T
    PLoS One; 2016; 11(2):e0147951. PubMed ID: 26840537
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Functional characterization of DNAM-1 (CD226) interaction with its ligands PVR (CD155) and nectin-2 (PRR-2/CD112).
    Tahara-Hanaoka S; Shibuya K; Onoda Y; Zhang H; Yamazaki S; Miyamoto A; Honda S; Lanier LL; Shibuya A
    Int Immunol; 2004 Apr; 16(4):533-8. PubMed ID: 15039383
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Increased CD112 expression in methylcholanthrene-induced tumors in CD155-deficient mice.
    Nagumo Y; Iguchi-Manaka A; Yamashita-Kanemaru Y; Abe F; Bernhardt G; Shibuya A; Shibuya K
    PLoS One; 2014; 9(11):e112415. PubMed ID: 25384044
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Boosting Natural Killer Cell-Mediated Targeting of Sarcoma Through DNAM-1 and NKG2D.
    Sayitoglu EC; Georgoudaki AM; Chrobok M; Ozkazanc D; Josey BJ; Arif M; Kusser K; Hartman M; Chinn TM; Potens R; Pamukcu C; Krueger R; Zhang C; Mardinoglu A; Alici E; Temple HT; Sutlu T; Duru AD
    Front Immunol; 2020; 11():40. PubMed ID: 32082316
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Development and Characterization of Novel Monoclonal Antibodies Against Human DNAM-1.
    Okumura G; Abe F; Hirochika R; Shibuya A; Shibuya K
    Monoclon Antib Immunodiagn Immunother; 2017 Jun; 36(3):135-139. PubMed ID: 28498033
    [TBL] [Abstract][Full Text] [Related]  

  • 6. DNAM-1 ligand expression on Ag-stimulated T lymphocytes is mediated by ROS-dependent activation of DNA-damage response: relevance for NK-T cell interaction.
    Ardolino M; Zingoni A; Cerboni C; Cecere F; Soriani A; Iannitto ML; Santoni A
    Blood; 2011 May; 117(18):4778-86. PubMed ID: 21406724
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression of CD226 is associated to but not required for NK cell education.
    Wagner AK; Kadri N; Snäll J; Brodin P; Gilfillan S; Colonna M; Bernhardt G; Höglund P; Kärre K; Chambers BJ
    Nat Commun; 2017 May; 8():15627. PubMed ID: 28561023
    [TBL] [Abstract][Full Text] [Related]  

  • 8. DNAM-1 controls NK cell activation via an ITT-like motif.
    Zhang Z; Wu N; Lu Y; Davidson D; Colonna M; Veillette A
    J Exp Med; 2015 Nov; 212(12):2165-82. PubMed ID: 26552706
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Establishment and characterization of a novel anti-DNAM-1 monoclonal antibody.
    Yamashita Y; Abe F; Hirochika R; Tahara-Hanaoka S; Shibuya A; Shibuya K
    Monoclon Antib Immunodiagn Immunother; 2013 Feb; 32(1):60-4. PubMed ID: 23600509
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of CD112R as a novel checkpoint for human T cells.
    Zhu Y; Paniccia A; Schulick AC; Chen W; Koenig MR; Byers JT; Yao S; Bevers S; Edil BH
    J Exp Med; 2016 Feb; 213(2):167-76. PubMed ID: 26755705
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification and characterization of murine DNAM-1 (CD226) and its poliovirus receptor family ligands.
    Tahara-Hanaoka S; Miyamoto A; Hara A; Honda S; Shibuya K; Shibuya A
    Biochem Biophys Res Commun; 2005 Apr; 329(3):996-1000. PubMed ID: 15752754
    [TBL] [Abstract][Full Text] [Related]  

  • 12. DNAM-1 and PVR regulate monocyte migration through endothelial junctions.
    Reymond N; Imbert AM; Devilard E; Fabre S; Chabannon C; Xerri L; Farnarier C; Cantoni C; Bottino C; Moretta A; Dubreuil P; Lopez M
    J Exp Med; 2004 May; 199(10):1331-41. PubMed ID: 15136589
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of PVR (CD155) and Nectin-2 (CD112) as cell surface ligands for the human DNAM-1 (CD226) activating molecule.
    Bottino C; Castriconi R; Pende D; Rivera P; Nanni M; Carnemolla B; Cantoni C; Grassi J; Marcenaro S; Reymond N; Vitale M; Moretta L; Lopez M; Moretta A
    J Exp Med; 2003 Aug; 198(4):557-67. PubMed ID: 12913096
    [TBL] [Abstract][Full Text] [Related]  

  • 14. PVR (CD155) and Nectin-2 (CD112) as ligands of the human DNAM-1 (CD226) activating receptor: involvement in tumor cell lysis.
    Pende D; Bottino C; Castriconi R; Cantoni C; Marcenaro S; Rivera P; Spaggiari GM; Dondero A; Carnemolla B; Reymond N; Mingari MC; Lopez M; Moretta L; Moretta A
    Mol Immunol; 2005 Feb; 42(4):463-9. PubMed ID: 15607800
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Blocking CD226 Promotes Allogeneic Transplant Immune Tolerance and Improves Skin Graft Survival by Increasing the Frequency of Regulatory T Cells in a Murine Model.
    Liu T; Zhang D; Zhang Y; Xu X; Zhou B; Fang L; Zhang Y; Su Y; Jin B; Zhuang R; Guo S
    Cell Physiol Biochem; 2018; 45(6):2338-2350. PubMed ID: 29550821
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immune checkpoint molecule DNAM-1/CD112 axis is a novel target for natural killer-cell therapy in acute myeloid leukemia.
    Kaito Y; Sugimoto E; Nakamura F; Tsukune Y; Sasaki M; Yui S; Yamaguchi H; Goyama S; Nannya Y; Mitani K; Tamura H; Imai Y
    Haematologica; 2024 Apr; 109(4):1107-1120. PubMed ID: 37731380
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification and functional analysis of ligands for natural killer cell activating receptors in colon carcinoma.
    Zhang Z; Su T; He L; Wang H; Ji G; Liu X; Zhang Y; Dong G
    Tohoku J Exp Med; 2012 Jan; 226(1):59-68. PubMed ID: 22189020
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CD155 on HIV-Infected Cells Is Not Modulated by HIV-1 Vpu and Nef but Synergizes with NKG2D Ligands to Trigger NK Cell Lysis of Autologous Primary HIV-Infected Cells.
    Davis ZB; Sowrirajan B; Cogswell A; Ward JP; Planelles V; Barker E
    AIDS Res Hum Retroviruses; 2017 Feb; 33(2):93-100. PubMed ID: 27296670
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Decreased expression of DNAM-1 on NK cells from acute myeloid leukemia patients.
    Sanchez-Correa B; Gayoso I; Bergua JM; Casado JG; Morgado S; Solana R; Tarazona R
    Immunol Cell Biol; 2012 Jan; 90(1):109-15. PubMed ID: 21383766
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CD155 mutation (Ala67Thr) increases the binding affinity for and the signaling via an inhibitory immunoreceptor TIGIT.
    Matsuo T; Iguchi-Manaka A; Shibuya A; Shibuya K
    Cancer Sci; 2022 Nov; 113(11):4001-4004. PubMed ID: 35947095
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.